| Primary |
| Product Used For Unknown Indication |
88.9% |
| Metabolic Acidosis |
11.1% |
|
| Toxicity To Various Agents |
33.3% |
| Ventricular Tachycardia |
33.3% |
| Wrong Technique In Drug Usage Process |
33.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
41.4% |
| Pneumonia |
29.3% |
| B-cell Lymphoma |
10.3% |
| Fluid Replacement |
5.2% |
| Anaesthesia |
3.4% |
| Product Used For Unknown Indication |
3.4% |
| Blood Bicarbonate Abnormal |
2.6% |
| Drug Toxicity Prophylaxis |
2.6% |
| Macular Degeneration |
0.9% |
| Wegener's Granulomatosis |
0.9% |
|
| Toxic Epidermal Necrolysis |
42.9% |
| Stomatitis |
21.4% |
| Endocarditis |
7.1% |
| Respiratory Arrest |
7.1% |
| Supraventricular Tachycardia |
7.1% |
| Wegener's Granulomatosis |
7.1% |
| Wrong Technique In Drug Usage Process |
7.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
61.9% |
| Prophylaxis Against Transplant Rejection |
4.9% |
| Multiple Myeloma |
4.4% |
| Prophylaxis |
3.8% |
| Renal Transplant |
3.1% |
| Acute Myeloid Leukaemia |
2.8% |
| Hypertension |
2.7% |
| Infection Prophylaxis |
1.7% |
| Pain |
1.7% |
| Renal Failure Chronic |
1.7% |
| Nuclear Magnetic Resonance Imaging |
1.6% |
| Hypotension |
1.5% |
| Burkitt's Lymphoma |
1.3% |
| Anaesthesia |
1.2% |
| Diffuse Large B-cell Lymphoma |
1.2% |
| Diabetes Mellitus |
1.0% |
| Peritoneal Dialysis |
1.0% |
| Blood Pressure Abnormal |
0.8% |
| Kidney Transplant Rejection |
0.8% |
| Non-small Cell Lung Cancer |
0.8% |
|
| Vomiting |
10.5% |
| Thrombocytopenia |
10.0% |
| Weight Decreased |
8.4% |
| White Blood Cell Count Decreased |
7.9% |
| Unresponsive To Stimuli |
7.4% |
| Sepsis |
6.3% |
| Renal Failure |
5.8% |
| Renal Impairment |
5.3% |
| Renal Failure Acute |
4.2% |
| Renal Failure Chronic |
4.2% |
| Weight Increased |
4.2% |
| Rash |
3.7% |
| Liver Function Test Abnormal |
3.2% |
| Respiratory Failure |
3.2% |
| Aplasia Pure Red Cell |
2.6% |
| Grand Mal Convulsion |
2.6% |
| Malaise |
2.6% |
| Pain In Extremity |
2.6% |
| Pneumonia |
2.6% |
| Shock |
2.6% |
|
